{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:02:06Z","timestamp":1793196126834,"version":"4.5.0"},"reference-count":101,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.00329","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T03:10:15Z","timestamp":1458702615000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":141,"title":["Infection with and Carriage of Mycoplasma pneumoniae in Children"],"prefix":"10.3389","volume":"7","author":[{"given":"Patrick M.","family":"Meyer Sauteur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy W. J.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Vink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie M. C.","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/adc.2010.208843","article-title":"Ciprofloxacin safety in paediatrics: a systematic review.","volume":"96","author":"Adefurin","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/cid\/civ473","article-title":"Neurological complications of PCR-proven M. pneumoniae infections in children: prodromal illness duration may reflect pathogenetic mechanism.","volume":"61","author":"Al-Zaidy","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0165-5728(02)00209-6","article-title":"Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barr\u00e9 syndrome.","volume":"130","author":"Ang","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s11882-013-0390-8","article-title":"Is asthma an infectious disease? New evidence.","volume":"13","author":"Atkinson","year":"2013","journal-title":"Curr. Allergy Asthma Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3201\/eid\/1706.101558","article-title":"Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.","volume":"17","author":"Averbuch","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s10096-003-1037-9","article-title":"Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents.","volume":"22","author":"Baer","year":"2003","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2217\/fmb.11.18","article-title":"Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.","volume":"6","author":"Bebear","year":"2011","journal-title":"Future Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1097\/INF.0000000000000063","article-title":"Comparison of Mycoplasma pneumoniae infections in asthmatic children versus asthmatic adults.","volume":"33","author":"Bebear","year":"2014","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1073\/pnas.1420308112","article-title":"Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae.","volume":"112","author":"Becker","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1128\/JCM.43.5.2277-2285.2005","article-title":"Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the \u201cgold standard\u201d.","volume":"43","author":"Beersma","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1086\/320748","article-title":"Acute childhood encephalitis and Mycoplasma pneumoniae.","volume":"32","author":"Bitnun","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"30078","key":"B13","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2015.20.48.30078","article-title":"Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015.","volume":"20","author":"Brown","year":"2015","journal-title":"Euro Surveill."},{"key":"B14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1128\/JCM.02840-12","article-title":"Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children.","volume":"51","author":"Cardinale","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1183\/09031936.00172510","article-title":"Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia.","volume":"37","author":"Cardinale","year":"2011","journal-title":"Eur. Respir. J."},{"key":"B16","first-page":"603","article-title":"Mycoplasma pneumoniae outbreak at a university \u2013 Georgia, 2012.","volume":"62","author":"Centers for Disease Control and Prevention [CDC]","year":"2013","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nmni.2015.05.005","article-title":"International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis.","volume":"7","author":"Chalker","year":"2015","journal-title":"New Microbes New Infect."},{"issue":"662","key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.140.3567.662","article-title":"Mycoplasma pneumoniae: proposed nomenclature for atypical pneumonia organism (Eaton agent).","volume":"140","author":"Chanock","year":"1963","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1056\/NEJM196003312621303","article-title":"Serologic evidence of infection with Eaton agent in lower respiratory illness in childhood.","volume":"262","author":"Chanock","year":"1960","journal-title":"N. Engl. J. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1073\/pnas.48.1.41","article-title":"Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.","volume":"48","author":"Chanock","year":"1962","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jama.1961.03040030037007","article-title":"Eaton agent pneumonia.","volume":"175","author":"Chanock","year":"1961a","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1073\/pnas.47.6.887","article-title":"Respiratory disease in volunteers infected with Eaton agent: a preliminary report.","volume":"47","author":"Chanock","year":"1961b","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/jac\/dkr003","article-title":"Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children.","volume":"66","author":"Chironna","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1542\/peds.2007-0240","article-title":"Pediatric encephalitis: what is the role of Mycoplasma pneumoniae?","volume":"120","author":"Christie","year":"2007a","journal-title":"Pediatrics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jneuroim.2007.06.017","article-title":"Anti-galactocerebroside testing in Mycoplasma pneumoniae-associated encephalitis.","volume":"189","author":"Christie","year":"2007b","journal-title":"J. Neuroimmunol."},{"key":"B26","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/08830738040190110401","article-title":"Diagnosis, treatment, and prognosis of Mycoplasma pneumoniae childhood encephalitis: systematic review of 58 cases.","volume":"19","author":"Daxboeck","year":"2004","journal-title":"J. Child Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10096-008-0591-6","article-title":"Role of Mycoplasma pneumoniae in pediatric encephalitis.","volume":"28","author":"Domenech","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1086\/318529","article-title":"Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs.","volume":"183","author":"Dorigo-Zetsma","year":"2001","journal-title":"J. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2012.02.014","article-title":"Optimized serodiagnosis of Mycoplasma pneumoniae infections.","volume":"73","author":"Dumke","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1469-0691.2009.02968.x","article-title":"Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.","volume":"16","author":"Dumke","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"B31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1084\/jem.79.6.649","article-title":"Studies on the etiology of primary atypical pneumonia: a filterable agent transmissible to cotton rats, hamsters, and chick embryos.","volume":"79","author":"Eaton","year":"1944","journal-title":"J. Exp. Med."},{"key":"B32","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3201\/eid1909.121466","article-title":"Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.","volume":"19","author":"Eshaghi","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1034\/j.1399-3003.2000.16f21.x","article-title":"Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing.","volume":"16","author":"Esposito","year":"2000","journal-title":"Eur. Respir. J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/01.inf.0000160949.99560.8d","article-title":"Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections.","volume":"24","author":"Esposito","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10096-002-0780-7","article-title":"Emerging role of Mycoplasma pneumoniae in children with acute pharyngitis.","volume":"21","author":"Esposito","year":"2002","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1099\/jmm.0.066191-0","article-title":"Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK.","volume":"62","author":"Ferguson","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/archpedi.156.10.1005","article-title":"Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia.","volume":"156","author":"Fischer","year":"2002","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/clinids\/17.Supplement_1.S37","article-title":"Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients.","volume":"17(Suppl. 1)","author":"Foy","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/infdis\/139.6.681","article-title":"Long-term epidemiology of infections with Mycoplasma pneumoniae.","volume":"139","author":"Foy","year":"1979","journal-title":"J. Infect. Dis."},{"key":"B40","first-page":"333","article-title":"Herpes oris conjunctivae.","volume":"14","author":"Fuchs","year":"1876","journal-title":"Klin. Monatsbl. Augenheilkd."},{"issue":"20110","key":"B41","article-title":"Increased reports of Mycoplasma pneumoniae from laboratories in Scotland in 2010 and 2011 \u2013 impact of the epidemic in infants.","volume":"17","author":"Gadsby","year":"2012","journal-title":"Euro Surveill."},{"issue":"CD004875","key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004875.pub5","article-title":"Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.","volume":"1","author":"Gardiner","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1017\/S0950268810000725","article-title":"Causality in acute encephalitis: defining aetiologies.","volume":"138","author":"Granerod","year":"2010","journal-title":"Epidemiol. Infect."},{"issue":"e7562","key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007562","article-title":"Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin.","volume":"4","author":"Hardy","year":"2009","journal-title":"PLoS ONE"},{"key":"B45","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2011-200598","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011.","volume":"66(Suppl. 2)","author":"Harris","year":"2011","journal-title":"Thorax"},{"key":"B46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.micpath.2013.07.004","article-title":"Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan.","volume":"64","author":"Hausner","year":"2013","journal-title":"Microb. Pathog."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1093\/nar\/24.22.4420","article-title":"Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae.","volume":"24","author":"Himmelreich","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3201\/eid1908.121455","article-title":"Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.","volume":"19","author":"Hong","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"B49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.17.06.20084-en","article-title":"Mycoplasma pneumoniae: now in the focus of clinicians and epidemiologists.","volume":"17","author":"Jacobs","year":"2012","journal-title":"Euro Surveill."},{"key":"B50","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ijmm.2015.08.021","article-title":"New insights in the outbreak pattern of Mycoplasma pneumoniae.","volume":"305","author":"Jacobs","year":"2015","journal-title":"Int. J. Med. Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children.","volume":"372","author":"Jain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1148\/radiographics.21.1.g01ja10121","article-title":"Spectrum of clinical and radiographic findings in pediatric mycoplasma pneumonia.","volume":"21","author":"John","year":"2001","journal-title":"Radiographics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00006454-200004000-00006","article-title":"Etiology of community-acquired pneumonia in 254 hospitalized children.","volume":"19","author":"Juven","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"6724","DOI":"10.1073\/pnas.0510644103","article-title":"ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens.","volume":"103","author":"Kannan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B55","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/cid\/cir769","article-title":"Fatal outcomes in family transmission of Mycoplasma pneumoniae.","volume":"54","author":"Kannan","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1212\/WNL.57.4.736","article-title":"Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry.","volume":"57","author":"Kusunoki","year":"2001","journal-title":"Neurology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/j.vaccine.2009.01.135","article-title":"Mycoplasma pneumoniae vaccine protective efficacy and adverse reactions\u2013Systematic review and meta-analysis.","volume":"27","author":"Linchevski","year":"2009","journal-title":"Vaccine"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s10096-010-0975-2","article-title":"Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods.","volume":"29","author":"Loens","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"591","key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-591","article-title":"Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.","volume":"13","author":"Matsuda","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/00007611-194609000-00005","article-title":"Primary atypical pneumonia.","volume":"39","author":"McCoy","year":"1946","journal-title":"South Med. J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00006454-198601000-00054","article-title":"Current status of antibiotic treatment for Mycoplasma pneumoniae infections.","volume":"5","author":"McCracken","year":"1986","journal-title":"Pediatr. Infect. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1165\/rcmb.2011-0135OC","article-title":"Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.","volume":"46","author":"Medina","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jaci.2005.03.023","article-title":"Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.","volume":"116","author":"Menge","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"w14041","key":"B64","article-title":"Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland.","volume":"144","author":"Meyer Sauteur","year":"2014a","journal-title":"Swiss Med. Wkly."},{"key":"B65","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1525-1470.2010.01200.x","article-title":"Fuchs syndrome associated with Mycoplasma pneumoniae (Stevens-Johnson syndrome without skin lesions).","volume":"28","author":"Meyer Sauteur","year":"2011","journal-title":"Pediatr. Dermatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1610-0387.2012.07951.x","article-title":"Mycoplasma pneumoniae and mucositis\u2013part of the Stevens-Johnson syndrome spectrum.","volume":"10","author":"Meyer Sauteur","year":"2012","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"B67","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1055\/s-0035-1566730","article-title":"Intrathecal anti-GalC antibodies in Bickerstaff brain stem encephalitis.","volume":"46","author":"Meyer Sauteur","year":"2015a","journal-title":"Neuropediatrics"},{"issue":"e1003983","key":"B68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003983","article-title":"Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis?","volume":"10","author":"Meyer Sauteur","year":"2014b","journal-title":"PLoS Pathog."},{"issue":"w14222","key":"B69","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2016.14222","article-title":"Swiss national prospective surveillance of paediatric Mycoplasma pneumoniae-associated encephalitis.","volume":"145","author":"Meyer Sauteur","year":"2016","journal-title":"Swiss Med. Wkly."},{"key":"B70","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0033-1348150","article-title":"Mycoplasma pneumoniae intrathecal antibody responses in Bickerstaff brain stem encephalitis.","volume":"45","author":"Meyer Sauteur","year":"2014c","journal-title":"Neuropediatrics"},{"key":"B71","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/jns.12121","article-title":"Severe childhood Guillain-Barr\u00e9 syndrome associated with Mycoplasma pneumoniae infection: a case series.","volume":"20","author":"Meyer Sauteur","year":"2015b","journal-title":"J. Peripher. Nerv. Syst."},{"key":"B72","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1542\/peds.113.4.701","article-title":"Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children.","volume":"113","author":"Michelow","year":"2004","journal-title":"Pediatrics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0140-6736(71)91956-8","article-title":"Delayed hypersensitivity in Mycoplasma pneumoniae infections.","volume":"1","author":"Mizutani","year":"1971","journal-title":"Lancet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/(SICI)1096-9071(199712)53:4324::AID-JMV33.0.CO;2-9","article-title":"The detection of intrathecal synthesis of anti-herpes simplex IgG antibodies: comparison between an antigen-mediated immunoblotting technique and antibody index calculations. European Union Concerted Action on Virus Meningitis and Encephalitis.","volume":"53","author":"Monteyne","year":"1997","journal-title":"J. Med. Virol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pediatrneurol.2009.04.012","article-title":"Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection.","volume":"41","author":"Narita","year":"2009","journal-title":"Pediatr. Neurol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10156-010-0044-x","article-title":"Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia.","volume":"16","author":"Narita","year":"2010","journal-title":"J. Infect. Chemother."},{"issue":"397","key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20445","article-title":"Cytokines involved in the severe manifestations of pulmonary diseases caused by Mycoplasma pneumoniae.","volume":"42","author":"Narita","year":"2007","journal-title":"Pediatr. Pulmonol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1086\/322709","article-title":"Two distinct patterns of central nervous system complications due to Mycoplasma pneumoniae infection.","volume":"33","author":"Narita","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.","volume":"55","author":"Okada","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/jac\/dkp160","article-title":"Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.","volume":"64","author":"Peuchant","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"20072","key":"B81","article-title":"Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010-2011.","volume":"17","author":"Polkowska","year":"2012","journal-title":"Euro Surveill."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1086\/319981","article-title":"Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.","volume":"32","author":"Principi","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF)\u2013a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.","volume":"122","author":"Reiber","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1097\/INF.0b013e3182611cee","article-title":"Management of macrolide-resistant Mycoplasma pneumoniae infection.","volume":"31","author":"Saegeman","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1126\/science.451555","article-title":"Experimental allergic neuritis induced by sensitization with galactocerebroside.","volume":"204","author":"Saida","year":"1979","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.neures.2012.09.006","article-title":"Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody.","volume":"74","author":"Samukawa","year":"2012","journal-title":"Neurosci. Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1365-4632.2009.04154.x","article-title":"Mycoplasma pneumoniae-induced cutaneous disease.","volume":"48","author":"Schalock","year":"2009","journal-title":"Int. J. Dermatol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1469-0691.2006.01636.x","article-title":"Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barr\u00e9 syndrome: a single centre prospective case-control study.","volume":"13","author":"Sinha","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"issue":"e1001444","key":"B89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001444","article-title":"Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study.","volume":"10","author":"Spuesens","year":"2013","journal-title":"PLoS Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1128\/JCM.00400-12","article-title":"Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands.","volume":"50","author":"Spuesens","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1099\/mic.0.028506-0","article-title":"Sequence variations in RepMP2\/3 and RepMP4 elements reveal intragenomic homologous DNA recombination events in Mycoplasma pneumoniae.","volume":"155","author":"Spuesens","year":"2009","journal-title":"Microbiology"},{"key":"B92","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1128\/IAI.58.8.2669-2674.1990","article-title":"Sequence divergency of the cytadhesin gene of Mycoplasma pneumoniae.","volume":"58","author":"Su","year":"1990","journal-title":"Infect. Immun."},{"key":"B93","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1574-6976.2011.00321.x","article-title":"Microbial antigenic variation mediated by homologous DNA recombination.","volume":"36","author":"Vink","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"B94","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","article-title":"Mycoplasma pneumoniae and its role as a human pathogen.","volume":"17","author":"Waites","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"issue":"CD009175","key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009175.pub2","article-title":"Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.","volume":"10","author":"Wang","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B96","doi-asserted-by":"publisher","first-page":"321.e1","DOI":"10.1016\/j.anai.2013.01.022","article-title":"Mycoplasma pneumoniae in children with acute and refractory asthma.","volume":"110","author":"Wood","year":"2013","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.09.032","article-title":"Incident asthma and Mycoplasma pneumoniae: a nationwide cohort study.","author":"Yeh","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/AAC.02060-12","article-title":"Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.","volume":"57","author":"Zhao","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3201\/eid2108.150273","article-title":"Macrolide-Resistant Mycoplasma pneumoniae, United States.","volume":"21","author":"Zheng","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More complications occurred in macrolide-resistant Mycoplasma pneumoniae pneumonia.","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B101","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1139\/w2012-041","article-title":"Protective immune responses in mice induced by intramuscular and intranasal immunization with a Mycoplasma pneumoniae P1C DNA vaccine.","volume":"58","author":"Zhu","year":"2012","journal-title":"Can. J. Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:38:03Z","timestamp":1655339883000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2016.00329\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,23]]},"references-count":101,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.00329","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,23]]}}}